mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0003 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0006 |